BioXcel Therapeutics - 53 Year Dividend History | BTAI
Historical dividend payout and yield for BioXcel Therapeutics (BTAI) since 1971. The current TTM dividend payout for BioXcel Therapeutics (BTAI) as of April 24, 2024 is $0.00. The current dividend yield for BioXcel Therapeutics as of April 24, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.110B |
$0.001B |
|
BioXcel Therapeutics Inc. is a clinical stage biopharmaceutical company. It focuses on drug development which utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company's product portfolio include BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. BioXcel Therapeutics Inc. is based in the United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
